[Early results of the treatment of diabetes with a (methyl-4-phenylsulfonyl)-1-[perhydrocyclopenta(C)pyrrolyl-2]-3-urea (gliclazide)
D000328:Adult; D000368:Aged; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005907:Gliclazide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D013997:Time Factors
D013453:Sulfonylurea Compounds; D005907:Gliclazide
Risultati iniziali sulla terapia del diabete con una (metil-4-fenilsulfonil)-1-[peridrociclopenta(C)pirrolil-2]-3-urea (gliclazide).